Objective The role of amino acid positron emission tomography (PET) in glioma grading and
outcome prognostication has not yet been well established. This is particularly true in the …

Abstract Purpose The World Health Organization Classification of Tumors of the Central
Nervous System has recently been updated by the integration of diagnostic and prognostic …

Background This translational study explores multi-tracer PET imaging for the non-invasive
detection of the IDH1 mutation which is a positive prognostic factor in glioma. Methods U87 …

Purpose We evaluated 18 F-FDOPA PET and MRI characteristics in association with the
molecular status and overall survival (OS) in a large number of low-grade gliomas (LGGs) …

Purpose The molecular features isocitrate dehydrogenase (IDH) mutation and 1p/19q co-
deletion have gained major importance for both glioma typing and prognosis and have …

Purpose This retrospective study aimed to correlate 18 F-FDG uptake on PET/CT with
isocitrate dehydrogenase enzyme isoform 1 (IDH1) mutation in patients with cerebral …

Objective: In diffuse Grade II–III gliomas, a high3, 4-dihydroxy-6-(18F)-fluoro-L-
phenylalanine (18F-FDOPA) positron emission tomography (PET) uptake, with a …

Dear Sir, Over the past few years, brain tumor imaging has been evaluated with several
radiolabeled amino acid radiopharmaceuticals for which the increased uptake is classically …

Amino-acid PET imaging is an efficient complementary tool to MRI for the assessment of
gliomas, principally for high-grade gliomas [1] and is now recommended by the Response …

Purpose According to the updated WHO classification of gliomas with its emphasis on
molecular parameters, tumours with an IDH-wildtype status have a dismal prognosis. To …